Regeneron announced that its REGN-COV2 investigational antibody cocktail therapy for the treatment of COVID-19, has been granted Emergency Use Authorization (EUA) by the US Food and...
In the disturbing scenario of human-to-mink-to-human COVID-19 transmission, the virus may mutate in mink prior to re-infecting people. That possibility makes vaccine design even more crucial.
U.S. stocks sold off after a sharp rally on Monday, ending the week fractionally lower. Utility names led the way lower, while the Energy sector was...
AstraZeneca starts new Covid-19 prevention trials of antibody cocktail
College-age kids and teens are drinking less alcohol – marijuana is a different story
A Vaccine & The "New-New Normal"
WHO says Gilead’s remdesivir should not be used in hospitalized Covid-19 patients
#MacroView: A Vaccine And The “New New Normal”
US Tops Off Worst Week Yet With Record 180k New COVID-19 Cases: Live Updates
Pfizer Expected to File FDA EUA Application for COVID-19 Vaccine Today
Media means business
Lilly’s baricitinib granted US emergency use in COVID-19
Mesoblast Teams Up With Novartis to Develop COVID-19/ARDS Stem Cell Therapy; Shares Up 17%
Eli Lilly Arthritis Drug Gets Emergency Green-Light As COVID-19 Treatment
NICE says yes to Braftovi combination for colorectal cancer
Amarin Pops 23% on Encouraging Late-Stage Vascepa Data from China Trial
We Need To Protect The Free Speech Of Dissident Doctors
FDA Grants EUA to Combination of Olumiant and Remdesivir in Hospitalized Covid-19 Patients
Scientific Collaboration Using Innovative Remote Technologies
Insights in the search for new antibiotics
Weill Cornell Researchers ID Specific Lung Changes in Covid-19
Billionaire Ken Griffin Bets on These 3 “Strong Buy” Stocks
Top Value Creation Play In Biocare
UPDATED: Eli Lilly's Covid-19 partner AbCellera pays $90M for some very special mice as Peter Thiel jumps on the board and IPO rumors heat up
Black people have a long history of poor medical treatment – no wonder many are hesitant to take COVID vaccines
Texas Heart Institute to participate in global stem cell study to treat ARDS due to COVID
Eli Lilly's Covid-19 partner AbCellera pays $90M for some very special mice as IPO rumors heat up
Pharma needs to adapt its communications or be left behind
In the lab, St. Jude scientists identify possible COVID-19 treatment
App could provide new way to track vaccine safety